Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination | springermedizin.de

Springer Medizin

nach oben

Frontiers of Medicine

Erschienen in:

30.09.2021 | Comment

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination

verfasst von: Prathit A. Kulkarni, Vinay Prasad

Erschienen in: Frontiers of Medicine | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Anzeige

Titel: Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
verfasst von: Prathit A. Kulkarni
Vinay Prasad
Publikationsdatum: 30.09.2021
Verlag: Higher Education Press
Erschienen in: Frontiers of Medicine / Ausgabe 6/2021
Print ISSN: 2095-0217
Elektronische ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-021-0895-9

Weitere Artikel der Ausgabe 6/2021

CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies

Review

18F-FDG-PET glucose hypometabolism pattern in patients with epileptogenic hypothalamic hamartoma

Research Article

Penetrance estimation of PRRT2 variants in paroxysmal kinesigenic dyskinesia and infantile convulsions

Research Article

Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018

Research Article

Erratum to: Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo

Erratum

Interactions between remote ischemic conditioning and post-stroke sleep regulation

Review

Home
Pseudoseite
- Apps
- Newsletter
- Abo-Shop
Service
- Jobbörse
- Info & Hilfe
Fachgebiete
Themen
Sammlungen